Improving non-small-cell lung cancer survival through molecular characterization: Perspective of a multidisciplinary expert panel

Fernandes, M. G. O.; Vilariça, A. S.; Fernandes, B.; Camacho, C.; Saraiva, C.; Estevinho, F.; Bastos, H. Novais e; Lopes, J. M.; Fidalgo, P.; Garrido, P.; Alves, S.; Silva, S.; Sequeira, T.; Barata, F.

http://hdl.handle.net/10400.1/26447

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
Improving non-small-cell lung cancer survival through molecular characterization: Perspective of a multidisciplinary expert panel.pdf		281.56 KB	Adobe PDF	Download

Send Feedback

Authors

Abstract(s)

The management of NSCLC remains challenging, and the integration of data from predictive biomarkers in routine clinical practice can contribute to an optimal, individualized patient approach, particularly given the rapid emergence of effective targeted therapies. When considering molecular biomarker testing, the choice of the biomarker panel, target population, testing approach, and turnaround time are key issues that, when properly addressed, can improve the survival outcomes of NSCLC patients.